Document is current
Any future updates will be listed below
-
Authors
Simões, Filipa C. https://orcid.org/0000-0003-2956-0311
Cahill, Thomas J.
Kenyon, Amy
Gavriouchkina, Daria https://orcid.org/0000-0002-7488-5898
Vieira, Joaquim M. https://orcid.org/0000-0003-2023-6304
Sun, Xin
Pezzolla, Daniela
Ravaud, Christophe https://orcid.org/0000-0002-0936-851X
Masmanian, Eva
Weinberger, Michael
Mayes, Sarah
Lemieux, Madeleine E. https://orcid.org/0000-0001-6355-8691
Barnette, Damien N.
Gunadasa-Rohling, Mala
Williams, Ruth M.
Greaves, David R. https://orcid.org/0000-0003-2856-9410
Trinh, Le A.
Fraser, Scott E.
Dallas, Sarah L.
Choudhury, Robin P. https://orcid.org/0000-0002-8046-1688
Sauka-Spengler, Tatjana https://orcid.org/0000-0001-9289-0263
Riley, Paul R. https://orcid.org/0000-0002-9862-7332
-
Funding
Funding for this research was provided by:
British Heart Foundation (RM/13/3/30159, RG/13/9/303269, CH/11/1/28798)
Wellcome Trust (106334/Z/14/Z)
Fondation Leducq (14CVD04)
- License Information
-
More Information
Article History
Received: 21 March 2019
Accepted: 27 December 2019
First Online: 30 January 2020
Competing interests
: R.P.C. and P.R.R. are co-founders and equity holders in OxStem Cardio, an Oxford University spin-out that seeks to exploit therapeutic strategies stimulating endogenous repair in cardiovascular regenerative medicine. The remaining authors declare no competing interests.
